STOCK TITAN

Concentra to repurchase 1M shares at $34.65

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. (CON) is the subject of an amended Schedule 13D filing by stockholder Robert A. Ortenzio. On August 21, 2026, Concentra agreed in a privately negotiated Stock Repurchase Agreement to repurchase 1,000,000 shares of its common stock from Ortenzio and related family trusts at $34.65 per share, for an aggregate purchase price of $34,650,000.

After these and other reported transactions, Ortenzio reports beneficial ownership of 6,748,222 shares of Concentra common stock, representing approximately 5.3% of the outstanding shares, based on 127,517,736 shares outstanding as of July 31, 2026. Of this amount, he reports sole voting and dispositive power over 4,763,794 shares and shared voting and dispositive power over 1,984,428 shares, including shares held by several family trusts.

Positive

  • None.

Negative

  • None.
Shares to be repurchased 1,000,000 shares Common stock repurchased under Stock Repurchase Agreement dated August 21, 2026
Repurchase price per share $34.65 per share Purchase price for shares repurchased from Ortenzio and related trusts
Aggregate repurchase price $34,650,000 Total consideration for 1,000,000 shares repurchased
Beneficially owned shares 6,748,222 shares Shares of Concentra common stock beneficially owned by Robert A. Ortenzio
Percent of class 5.3% Portion of Concentra common stock represented by Ortenzio’s beneficial ownership
Shares outstanding 127,517,736 shares Concentra common stock outstanding as of July 31, 2026
Sole voting and dispositive power 4,763,794 shares Shares over which Ortenzio has sole voting and dispositive power
Shared voting and dispositive power 1,984,428 shares Shares over which Ortenzio has shared voting and dispositive power
Stock Repurchase Agreement financial
"entered into that certain Stock Repurchase Agreement (the "Repurchase Agreement")"
beneficially own financial
"The Reporting Person may be deemed to beneficially own an aggregate of 6,748,222"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole voting power financial
"The Reporting Person may be deemed to have (a) the sole power to vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
shared dispositive power financial
"and (b) the shared power to vote or direct the vote of, and to dispose"
Schedule 13D regulatory
"If the filing person has previously filed a statement on Schedule 13G"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

FAQ

What major transaction involving CON stock is disclosed in this Schedule 13D/A?

Concentra Group Holdings Parent, Inc. entered into a Stock Repurchase Agreement on August 21, 2026 to repurchase 1,000,000 shares of its common stock from Robert A. Ortenzio and related trusts at $34.65 per share, for a total of $34,650,000.

What is Robert A. Ortenzio’s reported ownership stake in CON after this amendment?

Robert A. Ortenzio reports beneficial ownership of 6,748,222 CON shares, representing approximately 5.3% of Concentra’s common stock outstanding, based on 127,517,736 shares outstanding as of July 31, 2026.

How are voting and dispositive powers over CON shares divided for Robert A. Ortenzio?

Robert A. Ortenzio reports sole voting and dispositive power over 4,763,794 shares and shared voting and dispositive power over 1,984,428 shares of Concentra common stock, including shares held by various family trusts.

What price did Concentra agree to pay per share in the repurchase from Ortenzio and the trusts?

Concentra agreed to repurchase the shares at a price of $34.65 per share from Robert A. Ortenzio and the related trusts, for an aggregate purchase price of $34,650,000 for 1,000,000 shares.

Which entities besides Robert A. Ortenzio are selling CON shares under the repurchase agreement?

The sellers under the Repurchase Agreement are Robert A. Ortenzio, The Robert A. Ortenzio Descendants Trust, and three Robert A. Ortenzio 2014 Trusts for Bryan A., Kevin M., and Madeline G. Ortenzio.

On what share count is the 5.3% CON ownership figure based?

The 5.3% beneficial ownership figure is based on 127,517,736 shares of Concentra’s common stock outstanding as of July 31, 2026, as disclosed in the company’s Form 10-Q for the quarter ended June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





20603L102

(CUSIP Number)
Timothy F. Ryan
Concentra Group Holdings Parent, Inc., 5080 Spectrum Drive, Suite 1200W
Addison, TX, 75001
(972) 364-8000


Stephen M. Leitzell
Dechert LLP, 2929 Arch Street
Philadelphia, PA, 19104
(215) 994-2621

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
08/21/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Based on 127,517,736 shares of the Company's common stock outstanding as of July 31, 2026 as disclosed on Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed on August 6, 2026.


SCHEDULE 13D


Robert A. Ortenzio
Signature:Robert A. Ortenzio
Name/Title:/s/ Robert A. Ortenzio
Date:08/24/2026